Further, western blot analysis resulted in a decreased level of p-Akt in AD mouse brains compared to control, while the PTZ+ZOMEC group showed an increase in p-AKT expression compared with the PTZ group. The gene discussed is AKT1; the disease is Alzheimer disease.